KPV
Quick facts
- Researched for
- Gut inflammation, gut-barrier support, skin irritation, body-wide inflammation and joint or back discomfort
- Route or form
- Injection
- Evidence so far
- Findings come from mice, reports or a practitioner's take; no large human trial yet.
- Not established
- There is little human evidence for most of the uses people discuss.
- Commonly researched
- 250 mcg, once dailyPractitionerSee every range
- Where to get it
- At our partner, US Precision Peptides.Go to Next step
By the Learn Peptides editorial team · Updated · How We Research
What people are researching it for
People are researching KPV for gut inflammation, gut-barrier support, skin irritation, body-wide inflammation, and joint or back discomfort.
Calmer inflammation. A healthier you.
- What is KPV?
- a tripeptide composed of 3 amino acids
- Checklist: 3 amino acids (Lys-Pro-Val)
- How does it work?
- Taken up by PepT1 transporters
- NF-κB, MAPK
- Common research use cases
- Not written out in this text version.
- How it's used in research
- Route: Subcutaneous (most common)
- Route: Oral (popular for gut health)
- Route: Topical (skin research)
- Route: Combination protocols
- Common dosing: 200 to 500 mcg per day
- Common dosing: 1 mg per day (in some protocols)
- Common dosing: Duration typically 4 to 8 weeks (varies by research goal)
- Often combined with: BPC-157
- Often combined with: TB-500
- Often combined with: GHK-Cu
- Often combined with: Other research peptides
- There is no standardized dose or protocol. Research use should be thoughtful, tracked, and adjusted based on individual response.
- What users report
- Keep in mind: Results vary widely
- Keep in mind: Not everyone responds
- Keep in mind: Some report GI side effects (e.g., diarrhea, stomach upset)
- Keep in mind: More human studies are needed
- Key takeaway
- It's not a magic solution, but it represents a compelling area of research and is one of the most discussed peptides for a reason.
- The bottom line
- KPV shows strong potential in research for reducing inflammation and supporting gut, skin, and immune health, but more high-quality human studies are needed. Use only high-purity peptides, follow a research-focused approach, and set realistic expectations.
Reasons people look into KPV. An interest is not a promise that it works.
- Injury & recovery
- Gut health
- Immune support
KPV is in the 80 mg KLOW blend, its own product with its own amounts.
Blends that include KPV. A blend is its own product, with its own amounts.
Four peptides. Multiple pathways. A broader approach.
- What is the KLOW Stack?
- Checklist: Often supplied in an 80 mg blend (50:10:10:10)
- Vial illustrations: GHK-Cu 50 mg / BPC-157 10 mg / TB-500 10 mg / KPV 10 mg, each labelled "Research Use Only". The TB-500 in a KLOW vial is the TB-500 fragment.
- Checklist: Four complementary peptides
- How does it work?
- Sections: GHK-Cu; BPC-157; TB-500; KPV
- KPV sub-box: Anti-inflammatory (NF-κB pathway)
- Common research use cases
- Not written out in this text version.
- How it's used in research
- Route: Subcutaneous (and common)
- Route: Research protocols vary
- Route: Sometimes used individually or in combination
- Common blend: 80 mg total per vial
- Common blend: 50 mg GHK-Cu
- Common blend: 10 mg BPC-157
- Common blend: 10 mg TB-500
- Common blend: 10 mg KPV (ratios may vary by source)
- Typical research use: 1 to 2x per day
- Typical research use: Duration: 4 to 12 weeks (varies by goal)
- Typical research use: Often combined with proper nutrition, training, and recovery protocols
- There is no standardized dose or protocol. Research use should be thoughtful, tracked, and adjusted based on individual response.
- What users report
- Keep in mind: Results vary widely
- Keep in mind: Not everyone responds the same way
- Keep in mind: May help with symptoms, but long-term effects are still unknown
- Keep in mind: Use quality, independently tested products
- Key takeaway
- It's not a magic solution, but it may help you reach new goals by supporting multiple pathways in the body.
- The bottom line
- The KLOW Stack combines four peptides with complementary benefits. It may be a valuable research tool for people seeking multi-pathway support, but it's not risk-free. Use only high-purity peptides, follow a research-focused approach, and set realistic expectations.
People often report calmer flare-ups and less joint pain; others report no change or worse.
Community reports
People often report calmer gut, skin, or inflammation-related flare-ups and less joint or back discomfort. Others report no change or worsening symptoms.
Community reports
People use KPV mainly for gut bloating, joint and back pain, and calming mast-cell or histamine flare-ups, usually alongside other peptides in a . It's also popular as a small add-in to stop other peptides from stinging at the injection site, though that use is hard to separate from the dilution changes people make at the same time.
Cell and animal studies suggest it can calm inflammation, such as in the gut.
Cell and animal studies suggest KPV can turn down several inflammation signals, including in models of gut inflammation.
A small anti-inflammatory peptide that specifically targets the gut lining.
What this is based on
- Animal researchUseful for understanding a research question, but not the same as evidence in people.
- Community reportsWhat people describe noticing. Not proof of cause.
- Industry perspectiveCommentary from practitioners and the industry, based on experience. Not a study.
- Learn Peptides explanationOur own plain-English summary of the sources. It is not a source itself.
There is little human evidence for most of the uses people discuss.
Human evidence is limited for most of the uses discussed in peptide communities.
Safety notes
Seen in animal studies. Results in animals often do not carry over to people.
- You have trouble breathing or wheezing, or your face, lips, tongue or throat swell.
- You get hives away from the injection site, or feel severely dizzy or faint.
For these signs, call 911 or your local emergency number.
- Stop immediately if redness, fever, warmth, or pus appear at an injection site, since that suggests infection. Industry perspective
- Redness spreads, or heat, swelling or pain keeps growing where you injected.
- A lump keeps growing or does not go away, or you see pus or red streaks.
- You have a fever or chills, or feel sick all over.
- Avoid during pregnancy: no data exists. Industry perspective
- Separate dosing from antibiotics or ACE inhibitors, which compete for the same gut transporter. Industry perspective
- Oral KPV can cause a die-off reaction in people with gut dysbiosis. Industry perspective
- There is no human data past a few months of nonstop use. So the cited commentary says to take a break every 6 to 12 months as a precaution. Industry perspective
Shows 5 practitioner ranges, low to high, plus figures people report.
Commonly researched ranges, and how they were measured.
Commonly researched range for KPV
250 mcg
once daily · Injection
Practitioner
All 5 ranges in our record
Each one is labeled with where it comes from. They are different ways of using KPV, not steps to follow in order.
Standard, mild general inflammation
Practitioner- Amount per dose
- 250 mcg
- How often
- Once daily
- Typical schedule
- 4-6 weeks
- Route
- Injection
Active injury recovery (subcutaneous)
Practitioner- Amount per dose
- 500 mcg
- How often
- Once daily
- Typical schedule
- At least 6-8 weeks
- Route
- Injection
Severe inflammatory presentations
Practitioner- Amount per dose
- 1,000 mcg
- How often
- Once daily, split morning and evening (500 mcg each)
- Typical schedule
- 2-4 weeks, then step down to 500 mcg/day
- Route
- Injection
Injury stack (layered on BPC-157 + TB-500)
Practitioner- Amount per dose
- 500 mcg
- How often
- Once daily
- Typical schedule
- 6-12 weeks
- Route
- Injection
Stacked with BPC-157 (1:1 ratio)
Practitioner- Amount per dose
- 250 to 500 mcg
- How often
- Once or twice daily
- Typical schedule
- 6-8 weeks
- Route
- Injection
From our visual summary
Community reports
Community reports, from the Learn Peptides visual summary. These lines sit beside the ranges above and are not merged with them.
- Common dosing
- 200 to 500 mcg per day
- 1 mg per day (in some schedules)
- Duration typically 4 to 8 weeks (varies by goal)
There is no standard dose. Track how you respond, and change one thing at a time.
These ranges were last reviewed Sep 2026.
Check your syringe math with your own numbers.
This tiny peptide is mostly talked about as a way to calm gut inflammation.
KPV is a tiny, three-amino-acid peptide discussed mainly for calming inflammation, particularly around the gut, and around an injury site where inflammation is what's holding recovery back. It's usually discussed as a supporting compound rather than a 's centerpiece, most often paired with BPC-157 or TB-500.
Next step
US Precision Peptides
About product links
Purchases at US Precision Peptides help keep Learn Peptides free.